Start Date
April 30, 2002
Primary Completion Date
January 31, 2006
Study Completion Date
December 31, 2009
alvocidib
docetaxel
Memorial Sloan-Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center
OTHER